Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Erdafitinib. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113024518A details a streamlined 3-step halogenation route for Erdafitinib, offering high purity and reduced costs for pharmaceutical manufacturers.